A number of weeks earlier than the announcement, Vaxart granted amendments to the warrants agreements, which allowed Armistice to promote virtually all of their inventory, which they did as soon as the inventory value skyrocketed.
Vaxart has not been chosen by Operation Warp Speed to obtain analysis funding, however as a substitute had restricted involvement, HHS advised the New York Times in July. Vaxart’s vaccine, an oral pill, was solely concerned in preliminary research on primates sponsored by Warp Speed.
In an announcement to Source Business Saturday, the corporate stated, “The Vaxart non-human primate challenge study was organized and funded by Operation Warp Speed, as stated in the June 26, 2020 company press release. The statements made in that press release are accurate and any allegation to the contrary is baseless.”
In its October SEC submitting, Vaxart wrote that it has offered paperwork known as for by the subpoena to reveal its function in Operation Warp Speed. “The company has voluntarily provided documents requested by the SEC and is cooperating with this informal inquiry,” it acknowledged.
On October 14, Vaxart introduced encouraging outcomes from its research on hamsters that acquired oral dosages of its Covid-19 vaccine.
The inventory was down 3.5%, to roughly $6, as of Friday night.